Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AMRI | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

AMRI

Contract revenues were down 27% for AMRI in 3Q09

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI 3Q09

3Q Revenues: $47.7 million (-22%)

3Q Earnings: $0.4 million

YTD Revenues: $153.0 million (-12%)

YTD Earnings: $2.5 million

Comments: Total contract revenues dropped 27% to $39.7 million from 3Q08; Discovery Services was $11.9 million (-27%), Development/Small Scale Manufacturing was $9.7 million (-33%) and Large Scale Manufacturing was $18.2 million (-22%). Contract revenues are down 17% YTD to $121.8 million. Recurring royalties for the quarter were up 39% to $7.9 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters